Positivity for anti-SARS-CoV-2 IgA was observed in 10/86 HCWs (11.6%) as opposed to 66/556 (=11.9%), suggesting that although a more frequent and intensive contact with COVID-positive patients was present, this did not lead to higher rates of infection. This evidence concerns the gene CD79A and infection.